167 related articles for article (PubMed ID: 21147143)
1. Cyclization of conotoxins to improve their biopharmaceutical properties.
Clark RJ; Akcan M; Kaas Q; Daly NL; Craik DJ
Toxicon; 2012 Mar; 59(4):446-55. PubMed ID: 21147143
[TBL] [Abstract][Full Text] [Related]
2. Structural studies of conotoxins.
Daly NL; Craik DJ
IUBMB Life; 2009 Feb; 61(2):144-50. PubMed ID: 19165896
[TBL] [Abstract][Full Text] [Related]
3. Chemical modification of conotoxins to improve stability and activity.
Craik DJ; Adams DJ
ACS Chem Biol; 2007 Jul; 2(7):457-68. PubMed ID: 17649970
[TBL] [Abstract][Full Text] [Related]
4. Establishing regiocontrol of disulfide bond isomers of alpha-conotoxin ImI via the synthesis of N-to-C cyclic analogs.
Armishaw CJ; Dutton JL; Craik DJ; Alewood PF
Biopolymers; 2010; 94(3):307-13. PubMed ID: 20013812
[TBL] [Abstract][Full Text] [Related]
5. Engineering of conotoxins for the treatment of pain.
Carstens BB; Clark RJ; Daly NL; Harvey PJ; Kaas Q; Craik DJ
Curr Pharm Des; 2011 Dec; 17(38):4242-53. PubMed ID: 22204425
[TBL] [Abstract][Full Text] [Related]
6. Effects of cyclization on stability, structure, and activity of α-conotoxin RgIA at the α9α10 nicotinic acetylcholine receptor and GABA(B) receptor.
Halai R; Callaghan B; Daly NL; Clark RJ; Adams DJ; Craik DJ
J Med Chem; 2011 Oct; 54(19):6984-92. PubMed ID: 21888386
[TBL] [Abstract][Full Text] [Related]
7. Engineering cyclic peptide toxins.
Clark RJ; Craik DJ
Methods Enzymol; 2012; 503():57-74. PubMed ID: 22230565
[TBL] [Abstract][Full Text] [Related]
8. Native chemical ligation applied to the synthesis and bioengineering of circular peptides and proteins.
Clark RJ; Craik DJ
Biopolymers; 2010; 94(4):414-22. PubMed ID: 20593458
[TBL] [Abstract][Full Text] [Related]
9. Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII.
Clark RJ; Fischer H; Dempster L; Daly NL; Rosengren KJ; Nevin ST; Meunier FA; Adams DJ; Craik DJ
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13767-72. PubMed ID: 16162671
[TBL] [Abstract][Full Text] [Related]
10. The chemical synthesis of α-conotoxins and structurally modified analogs with enhanced biological stability.
Banerjee J; Gyanda R; Chang YP; Armishaw CJ
Methods Mol Biol; 2013; 1081():13-34. PubMed ID: 24014431
[TBL] [Abstract][Full Text] [Related]
11. AlphaA-Conotoxin OIVA defines a new alphaA-conotoxin subfamily of nicotinic acetylcholine receptor inhibitors.
Teichert RW; Rivier J; Dykert J; Cervini L; Gulyas J; Bulaj G; Ellison M; Olivera BM
Toxicon; 2004 Aug; 44(2):207-14. PubMed ID: 15246771
[TBL] [Abstract][Full Text] [Related]
12. Conus venoms: a rich source of novel ion channel-targeted peptides.
Terlau H; Olivera BM
Physiol Rev; 2004 Jan; 84(1):41-68. PubMed ID: 14715910
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of α-conotoxin AuIB: influences of disulfide connectivity and backbone cyclization.
Lovelace ES; Gunasekera S; Alvarmo C; Clark RJ; Nevin ST; Grishin AA; Adams DJ; Craik DJ; Daly NL
Antioxid Redox Signal; 2011 Jan; 14(1):87-95. PubMed ID: 20486767
[TBL] [Abstract][Full Text] [Related]
14. Molecular Engineering of Conus Peptides as Therapeutic Leads.
Daniel JT; Clark RJ
Adv Exp Med Biol; 2017; 1030():229-254. PubMed ID: 29081056
[TBL] [Abstract][Full Text] [Related]
15. NMR solution structure of alpha-conotoxin ImI and comparison to other conotoxins specific for neuronal nicotinic acetylcholine receptors.
Rogers JP; Luginbühl P; Shen GS; McCabe RT; Stevens RC; Wemmer DE
Biochemistry; 1999 Mar; 38(13):3874-82. PubMed ID: 10194298
[TBL] [Abstract][Full Text] [Related]
16. Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter.
Lovelace ES; Armishaw CJ; Colgrave ML; Wahlstrom ME; Alewood PF; Daly NL; Craik DJ
J Med Chem; 2006 Nov; 49(22):6561-8. PubMed ID: 17064074
[TBL] [Abstract][Full Text] [Related]
17. Transforming conotoxins into cyclotides: Backbone cyclization of P-superfamily conotoxins.
Akcan M; Clark RJ; Daly NL; Conibear AC; de Faoite A; Heghinian MD; Sahil T; Adams DJ; Marí F; Craik DJ
Biopolymers; 2015 Nov; 104(6):682-92. PubMed ID: 26172377
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure at 1.1 A resolution of alpha-conotoxin PnIB: comparison with alpha-conotoxins PnIA and GI.
Hu SH; Gehrmann J; Alewood PF; Craik DJ; Martin JL
Biochemistry; 1997 Sep; 36(38):11323-30. PubMed ID: 9298951
[TBL] [Abstract][Full Text] [Related]
19. Conotoxins: Chemistry and Biology.
Jin AH; Muttenthaler M; Dutertre S; Himaya SWA; Kaas Q; Craik DJ; Lewis RJ; Alewood PF
Chem Rev; 2019 Nov; 119(21):11510-11549. PubMed ID: 31633928
[TBL] [Abstract][Full Text] [Related]
20. Conotoxins: molecular and therapeutic targets.
Lewis RJ
Prog Mol Subcell Biol; 2009; 46():45-65. PubMed ID: 19184584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
